BACKGROUND: Genetic factors and previous alcohol experience influence alcohol consumption in both humans and rodents. Specifically, a prior experience with ethanol increases ethanol intake in both ethanol-preferring C57BL/6 (C57) and ethanol non-preferring DBA/2 (DBA) mice. Whereas the ventral tegmental area (VTA) importantly regulates dopamine levels and ethanol intake, it is unknown whether ethanol experience differentially alters synaptic properties of VTA dopamine neurons in ethanol-preferring and non-preferring mice. METHODS: The properties of excitatory and inhibitory inputs and the ability to elicit long-term potentiation (LTP) were assessed with whole-cell patch-clamp recordings in VTA dopamine neurons from C57 and DBA mice 24 hours after a single ethanol (2 g/kg, IP) or equivalent saline injection. RESULTS: Ethanol exposure increased gamma-aminobutyric acid (GABA) release onto VTA dopamine neurons in DBA mice, as previously observed in C57 mice. However, a single ethanol exposure reduced alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR) function and LTP in VTA dopamine neurons from DBA but not C57 mice. CONCLUSIONS: A single ethanol exposure selectively reduced glutamate receptor function in VTA dopamine neurons from the ethanol non-preferring DBA strain but enhanced GABA signaling in both C57 and DBA strains. These results support the notion that VTA dopamine neurons are a central target of ethanol-induced neural plasticity, which could contribute to ethanol consumption. Furthermore, these findings highlight the possible need for specialized therapeutic interventions for alcoholism based on individual intrinsic differences.
BACKGROUND: Genetic factors and previous alcohol experience influence alcohol consumption in both humans and rodents. Specifically, a prior experience with ethanol increases ethanol intake in both ethanol-preferring C57BL/6 (C57) and ethanol non-preferring DBA/2 (DBA) mice. Whereas the ventral tegmental area (VTA) importantly regulates dopamine levels and ethanol intake, it is unknown whether ethanol experience differentially alters synaptic properties of VTA dopamine neurons in ethanol-preferring and non-preferring mice. METHODS: The properties of excitatory and inhibitory inputs and the ability to elicit long-term potentiation (LTP) were assessed with whole-cell patch-clamp recordings in VTA dopamine neurons from C57 and DBAmice 24 hours after a single ethanol (2 g/kg, IP) or equivalent saline injection. RESULTS:Ethanol exposure increased gamma-aminobutyric acid (GABA) release onto VTA dopamine neurons in DBAmice, as previously observed in C57 mice. However, a single ethanol exposure reduced alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor (AMPAR) and N-methyl-D-aspartate receptor (NMDAR) function and LTP in VTA dopamine neurons from DBA but not C57 mice. CONCLUSIONS: A single ethanol exposure selectively reduced glutamate receptor function in VTA dopamine neurons from the ethanol non-preferring DBA strain but enhanced GABA signaling in both C57 and DBA strains. These results support the notion that VTA dopamine neurons are a central target of ethanol-induced neural plasticity, which could contribute to ethanol consumption. Furthermore, these findings highlight the possible need for specialized therapeutic interventions for alcoholism based on individual intrinsic differences.
Authors: Alexander O Komendantov; Olena G Komendantova; Steven W Johnson; Carmen C Canavier Journal: J Neurophysiol Date: 2003-09-17 Impact factor: 2.714
Authors: Alexis W Ary; Debra K Cozzoli; Deborah A Finn; John C Crabbe; Marlin H Dehoff; Paul F Worley; Karen K Szumlinski Journal: Alcohol Date: 2012-03-22 Impact factor: 2.405
Authors: Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris Journal: J Neurochem Date: 2011-05-03 Impact factor: 5.372
Authors: Elizabeth M Avegno; Michael C Salling; Anders Borgkvist; Ana Mrejeru; Alexander C Whitebirch; Elyssa B Margolis; David Sulzer; Neil L Harrison Journal: Neuropharmacology Date: 2016-07-27 Impact factor: 5.250